D-66014-001 Class II Terminated
FDA drug recall D-66014-001 was initiated by Amneal Pharmaceuticals Of New York, LLC. on Aug 17, 2013 and is designated Class II. Reason for recall: Failed dissolution specifications; 18 month CRT The recall status is terminated (terminated Jul 17, 2014). Affected quantity: 895 - 1000 count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 13, 2013
- Initiation Date
- Aug 17, 2013
- Termination Date
- Jul 17, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 895 - 1000 count bottles
Product description
Extended Phenytoin Sodium Capsules, USP, 100 mg, 1000 CAPSULES, Rx only, amneal PHARMACEUTICALS label, NDC 65162-212-11 --- Manufactured by: Amneal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Amneal Pharmaceuticals Glasgow, KY 42141
Reason for recall
Failed dissolution specifications; 18 month CRT
Distribution pattern
IL, NH, NJ, NY, OH, RI, TN
Code information
Batch/Lot HL50611, exp. 1/2014
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-66014-001
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026